RSK Medical
RSK Medical Inc. is a privately held Canadian specialty medical device distributor that holds exclusive nationwide Canadian distribution rights for 12+ differentiated interventional cardiology, radiology, surgery, ICU/trauma, and electrophysiology devices sourced from international manufacturers, selling to Canadian hospitals and physicians via a direct sales force.
- Company typePrivate
- Founded2013
- HeadquartersMississauga, Canada
- Headcount1–10
- GTM typeB2B
- OfferingServices
What RSK Medical does
RSK Medical Inc. is a privately held, wholly Canadian-owned specialty medical device distributor headquartered in Mississauga, Ontario, that holds exclusive nationwide Canadian distribution rights for a portfolio of differentiated medical devices sourced from international manufacturers. Founded and led by President Scott Kadwell, who brings 40+ years of cardiovascular medical device experience with prior senior roles at SulzerMedica, Guidant, BSC, Medtronic, and Sorin Group, the company sells exclusively to Canadian hospitals and interventional physicians across five clinical verticals: interventional cardiology, interventional radiology, cardiac/vascular/endovascular surgery, ICU/Emergency/Trauma, and electrophysiology, with a secondary patients/consumers vertical for postoperative support products.
The portfolio is a curated set of acquired and distributed brands rather than an integrated platform. Flagship products include the Meril Life Myval Octacor balloon-expandable TAVI system (lowest-profile BE valve in the Canadian marketplace, Health Canada approved Feb 2026), the Angiodroid Automated Carbon Dioxide Angiography system (Health Canada approved Feb 2025), the NeoChord trans-apical beating-heart mitral repair device, the AngioSafe Santreva-ATK wire-free peripheral CTO crossing catheter (FDA 510(k) cleared and CE marked in 2025), the Mermaid Medical Angel Catheter (first FDA-cleared IVC filter for prophylactic use), Texray radiation protection textiles (reducing scatter radiation by up to 97%), Venus-Medtech's Venus-P transcatheter pulmonary valve, Occlutech minimally invasive cardiac implants, TricValve, Pocket Press CIED pressure bandages, Abyrx MONTAGE sternal bone putty, and Qualiteam QualiBreath/QualiBra postoperative supports. Clinical validation anchors include 21,000+ global Myval implants, 1,000+ TricValve implants, 35,000+ MONTAGE applications, and 20+ clinical studies validating Angiodroid safety and efficacy.
RSK Medical operates a pure distribution model with revenue generated through resale of manufacturer products to Canadian healthcare providers via a lean direct sales force (President and Director of Sales Greg Whitwham, who operates in a full-time consultant role, supported by clinical proctors from manufacturer partners). The company does not manufacture, does not disclose pricing, and does not publicize revenue. Its economic value proposition is regulatory expertise (repeatedly securing Health Canada firsts), clinical-relationship depth across major Canadian academic centers, and the ability to shepherd novel international devices through Canadian market entry without the overhead of a manufacturer-owned sales infrastructure.
RSK Medical firmographics
Firmographics- Name
- RSK Medical
- Legal name
- RSK Medical Inc.
- Website
- https://rskmedical.com
- Company type
- Private
- Founded year
- 2013
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- RSK Medical Inc. is a privately held Canadian specialty medical device distributor that holds exclusive nationwide Canadian distribution rights for 12+ differentiated interventional cardiology, radiology, surgery, ICU/trauma, and electrophysiology devices sourced from international manufacturers, selling to Canadian hospitals and physicians via a direct sales force.
- Ownership category
- akta.pro rank
RSK Medical industry classification
Industry- Product category
- Medical Device Distribution
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Services-Misc Health & Allied Services, Nec (8090)
- akta.pro primary industry
- Structural Heart Valves (TAVR/SAVR) & Valve Repair (HLAHAFAB)
Keywords
Where RSK Medical is headquartered
LocationHeadquarters
- HQ city
- Mississauga
- HQ country
- Canada
- HQ region
- North America
Offices1 record
Markets served
RSK Medical business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Supply Chain, Others
Revenue model
- Medical Device Distribution: RSK Medical generates revenue through distribution agreements with international medical device manufacturers, reselling and distributing their products to hospitals and physicians across Canada.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
RSK Medical product offering
Product offeringCore offering
RSK Medical is a Canadian medical device distributor that enters into nationwide distribution agreements with international medical device manufacturers and resells their proprietary cardiovascular, endovascular, and surgical devices to hospitals and physicians across Canada. The company distributes products across interventional cardiology, interventional radiology, cardiac/vascular/endovascular surgery, ICU/Emergency/Trauma, and electrophysiology specialties through a direct field sales force.
Product overview
RSK Medical is a Canadian medical device distributor operating as a portfolio of distributed brands rather than a unified platform. The company serves interventional cardiology, radiology, cardiac/vascular/endovascular surgery, ICU/Emergency/Trauma, and electrophysiology clinical communities. Their product portfolio consists of acquired and distributed brands including transcatheter valve systems (Myval Octacor TAVI, Venus-P, TricValve), structural heart repair devices (NeoChord), endovascular devices (Santreva-ATK, Angiodroid CO2 system), IVC filters (Angel Catheter), radiation protection (Texray), surgical support products (MONTAGE Bone Putty, QualiBreath, QualiBra), and electrophysiology accessories (Pocket Press). These products are distributed under various distribution agreements with international manufacturers and are not integrated into a single technical platform.
Differentiator
Problem solved
Functional benefit
Products and services
- Myval Octacor TAVI System Balloon-expandable transcatheter aortic valve (TAVI) system with the lowest profile in the Canadian marketplace, available in regular, intermediate, and XL sizes. Distributed to Canadian hospitals and interventional cardiologists for TAVI procedures. Over 21,000 patient implants globally.
- Angiodroid Automated Carbon Dioxide Angiography (ACDA) System Automated CO2 angiography system that uses carbon dioxide as a contrast agent alternative for patients with kidney disease or contrast allergies, providing imaging while preserving renal function. Validated in over 20 international clinical studies. Distributed to Canadian interventional radiologists for venous and arterial procedures.
- Angel Catheter FDA-cleared IVC filter permanently attached to a triple-lumen central venous catheter, providing immediate PE protection with guaranteed retrieval for critically ill patients. Allows bedside placement without endovascular suite. Distributed to Canadian ICU, emergency, and trauma departments.
- Texray Radiation Protection Textile Radiation protection textile that can reduce scatter radiation towards the head and neck by up to 97%, designed for use during interventional electrophysiology, cardiology, radiology, and endovascular surgery procedures. Distributed to Canadian hospitals and EP labs.
- NeoChord Trans-Apical Beating Heart Device Minimally invasive mitral valve repair device that uses a trans-apical approach while the heart is beating, without cardio-pulmonary bypass or aortic cross-clamping. Distributed to Canadian cardiac surgery departments for mitral regurgitation treatment.
- Santreva-ATK Endovascular Revascularization Catheter Wire-free intraluminal peripheral CTO crossing catheter using proprietary Atheroplasty technology for simultaneous plaque compression and recanalization. FDA 510(k) cleared and CE marked. Distributed to Canadian interventional radiologists and vascular surgeons for peripheral CTO procedures.
- Pocket Press CIED Pressure Bandage Pre-assembled pressure bandage specifically designed for pacemaker and ICD implants with 3-anchor design and high-density foam for consistent pocket compression to reduce hematomas. Distributed to Canadian electrophysiology labs and cardiology departments performing CIED implantation.
- Venus-P Transcatheter Pulmonary Valve Self-expanding multi-level support frame with tri-leaflet pericardium tissue valve for transcatheter pulmonary valve replacement, available in 5 diameters in 25mm and 30mm lengths. Distributed to Canadian cardiac surgery departments.
- TricValve Transcatheter Bicaval Valves System System consisting of two self-expanding valves for percutaneous treatment of severe tricuspid regurgitation and caval reflux, implanted into the inferior and superior vena cava. Over 1,000 implants worldwide. Distributed to Canadian cardiac surgery and interventional cardiology departments.
- MONTAGE Sternal Bone Putty Settable, resorbable hemostatic bone putty for sternal closure after open heart surgery, used with sternotomy wires and/or sternal plates. Bioabsorbable polymer that hardens within 4 minutes. Over 35,000 cranial, spinal, and orthopedic patient applications. Distributed to Canadian cardiac surgery departments.
- Occlutech Cardiac Devices Portfolio of minimally invasive cardiac implants including PFO, ASD, and VSD devices designed for Congenital Heart Disease, Stroke Prevention, Adult Intervention, and Heart Failure. Distributed to Canadian interventional cardiology and cardiac surgery departments.
- QualiBreath Postoperative Sternum & Thorax Support Chest surrounding sternum support with integrated handles for increased support after sternotomy or other chest interventions, available in all sizes for adults, pediatric, and infant patients. Distributed to Canadian patients and hospitals for postoperative care after open heart surgery.
- QualiBra Advanced Postoperative Support Nurse-designed postoperative sternum and breast support specifically designed for women seeking comfort and practicality in one device. Distributed to Canadian patients after open heart surgery.
Quantifiable outcome
- Myval Octacor TAVI has been implanted in over 21,000 patients globally, with Health Canada approval obtained February 2026.
- +3 more outcomes
Companies that use RSK Medical
Customer profileNamed customers6 records
Segments6 records
Ideal customer profiles5 records
RSK Medical technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature8 records
RSK Medical partnerships and signals
Strategic signalPartnerships
Ten partnerships are on record, tiered core and minor.
- AngioSafe, Inc.coreRSK Medical announced a nationwide distribution agreement with AngioSafe, Inc. (San Jose, CA) in July 2025. AngioSafe developed a novel wire-free catheter-based CTO crossing technology (Santreva-ATK Endovascular Revascularization Catheter) enabled by proprietary Atheroplasty technology. The device received FDA 510(k) clearance and CE marking in 2025.
- Mermaid MedicalcoreRSK Medical announced a nationwide distribution agreement with Mermaid Medical (Denmark) for their Angel Catheter — the first FDA-cleared IVC filter approved for prophylactic use. The Danish company distributes and develops medical devices primarily within interventional radiology and the vascular system.
- Meril Life SciencescoreRSK Medical announced a nationwide distribution agreement with Meril Life Sciences (India) for their Myval Octacor Transcatheter Heart Valve (THV). The Myval Octacor device has been implanted in over 21,000 patients globally. Health Canada regulatory approval for the Myval Octacor TAVI system was obtained February 25, 2026, and RSK Medical announced the approval the same day.
- Abyrx Inc.minorRSK Medical announced representation of MONTAGE XT, a settable, resorbable, hemostatic bone putty manufactured by Abyrx Inc. for sternal closure after open heart surgery. The bioabsorbable polymer is Health Canada and FDA cleared with over 35,000 patient applications.
- OcclutechcoreRSK Medical announced a nationwide distribution agreement with Occlutech (Sweden), a leading specialist of minimally invasive cardiac devices effective May 1, 2024. Occlutech has developed, manufactured, and commercialized minimally invasive implants for over 20 years, offering PFO, ASD, VSD devices, and products for congenital heart disease, stroke prevention, and heart failure.
- Venus-MedtechcoreRSK Medical announced a distribution agreement with Venus-Medtech, a leader in transcatheter structural heart valve therapies in Asia and Europe. RSK Medical distributes the Venus-P Valve system — the first self-expanding nitinol stent designed specifically for pulmonary valve replacement. Venus-P received Class IV Health Canada approval January 30, 2024.
- Texray ABcoreRSK Medical announced a nationwide distribution agreement with Texray AB (Kungsbacka, Sweden) effective immediately. Texray invented the only radiation protection textile in the world, reducing scatter radiation towards head and neck by up to 97% using a woven textile technology.
- Angiodroid SrlcoreRSK Medical signed a long-term Canada-wide agreement to represent Angiodroid Srl from Bologna, Italy in March 2021. Angiodroid manufactures The CO2 Injector, the first system for Automated Carbon Dioxide Angiography (ACDA). Health Canada regulatory approval was obtained February 3, 2025.
- NeoChord Inc.coreRSK Medical announced a distribution agreement with NeoChord Inc., a privately held medical technology company advancing mitral valve repair. The NeoChord procedure is a beating heart, echo-guided treatment for mitral regurgitation, allowing minimally invasive repair without cardio-pulmonary bypass.
- QualiteamminorQualiteam is dedicated to advancing postoperative care and improving hospital experience for patients worldwide through innovative wound supports. RSK Medical distributes QualiBreath and QualiBra Advanced postoperative sternum and chest support products across Canada.
Scale indicators5 records
Recent moves6 records
Expansion highlights5 records
RSK Medical competitors and assessment
Company assessmentBroad incumbents
- Cardinal Health: Large medical products distributor with significant Canadian presence serving hospitals and clinicians across multiple specialties — comparable to RSK Medical in its role as a multi-manufacturer distribution channel into the Canadian healthcare system.
- Medtronic: Multinational medical device incumbent with a large Canadian sales force across interventional cardiology, structural heart, and cardiac surgery — the same specialties RSK Medical serves. Medtronic's Evolut TAVI competes head-to-head with RSK's Myval Octacor distribution rights.
- Boston Scientific: Diversified cardiovascular device manufacturer with significant Canadian presence across interventional cardiology, structural heart, and peripheral vascular — directly overlapping RSK Medical's portfolio focus areas.
- Abbott: Multinational incumbent with structural heart (Navitor TAVI), vascular, and electrophysiology product lines in Canada — competing with several of RSK Medical's distributed brands for hospital contracts and clinician mindshare.
- Teleflex: Diversified specialty medical device manufacturer with interventional cardiology, vascular access, and surgical portfolios — comparable to RSK Medical's multi-specialty clinical coverage and Canadian hospital channel.
Direct peers
- Edwards Lifesciences: Global structural heart leader and manufacturer of the Sapien TAVI system, directly competing with RSK Medical's distributed Myval Octacor TAVI in the Canadian transcatheter aortic valve market. Both target interventional cardiologists and cardiac surgeons at major Canadian hospitals.
- Merit Medical Systems: Specialty medical device company focused on interventional cardiology, interventional radiology, and endovascular procedures — directly overlapping RSK Medical's clinical segments with a comparable specialty-distribution model.
- Conmed: Specialty medical device manufacturer and distributor serving interventional cardiology, surgery, and critical care — comparable to RSK Medical in being a focused, multi-specialty distributor rather than a broad-line incumbent.
- AngioDynamics: Specialty medical device company in peripheral vascular disease and oncology — overlapping with RSK Medical's interventional radiology and endovascular surgery focus areas with comparable go-to-market model.
- Penumbra: Specialty interventional device company in vascular thrombectomy and peripheral intervention — comparable to RSK Medical as a focused player serving interventional radiology and vascular surgery channels.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
RSK Medical social profiles
Digital presenceRSK Medical financial estimates
Financial estimateRevenue estimate
Valuation estimate
RSK Medical leadership team
Management profileNumber of profiles
Profiles4 records
RSK Medical funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
RSK Medical M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about RSK Medical
What does RSK Medical do?
RSK Medical is a Canadian medical device distributor that enters into nationwide distribution agreements with international medical device manufacturers and resells their proprietary cardiovascular, endovascular, and surgical devices to hospitals and physicians across Canada. The company distributes products across interventional cardiology, interventional radiology, cardiac/vascular/endovascular surgery, ICU/Emergency/Trauma, and electrophysiology specialties through a direct field sales force.
Is RSK Medical a public or private company?
RSK Medical is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was RSK Medical founded?
RSK Medical was founded in 2013. It employs 1 to 10 people.
Where is RSK Medical based?
RSK Medical is headquartered in Mississauga, Canada, in the North America region.
How does RSK Medical make money?
One revenue line is on record: medical Device Distribution.
Who are RSK Medical's main competitors?
Broad incumbents on record are Cardinal Health, Medtronic, Boston Scientific, Abbott and Teleflex. Direct peers are Edwards Lifesciences, Merit Medical Systems, Conmed, AngioDynamics and Penumbra.
Does RSK Medical have an API?
No public API is recorded for RSK Medical.
What industry is RSK Medical in?
RSK Medical's product category is Medical Device Distribution. Its primary akta.pro industry code is HLAHAFAB, Structural Heart Valves (TAVR/SAVR) & Valve Repair. Its SIC code is 3841.